Stay updated on Anetumab Ravtansine Multi-indication Clinical Trial

Sign up to get notified when there's something new on the Anetumab Ravtansine Multi-indication Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Anetumab Ravtansine Multi-indication Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    Core study details, eligibility criteria, outcomes, and locations appear unchanged; the observed differences seem limited to cosmetic or layout changes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-10-28T05:19:45.000Z thumbnail image
  3. Check
    30 days ago
    Change Detected
    Summary
    Significant update: new operating-status notice and version bump to v3.2.0; previous v3.1.0 reference removed.
    Difference
    3%
    Check dated 2025-10-06T16:09:23.000Z thumbnail image
  4. Check
    37 days ago
    Change Detected
    Summary
    The page update adds the new version tag v3.1.0 and removes the old v3.0.2 tag, signaling a software version upgrade.
    Difference
    0.1%
    Check dated 2025-09-29T10:08:44.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    Version bump from v3.0.1 to v3.0.2 and removal of the 'Back to Top' button; no other substantive changes.
    Difference
    0.2%
    Check dated 2025-09-15T00:57:50.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, pricing, or availability.
    Difference
    0.2%
    Check dated 2025-09-07T23:00:08.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The webpage has been updated to include new drug information and resources related to various cancers, as well as specific facility names and locations. Some previously listed locations and resources have been removed.
    Difference
    12%
    Check dated 2025-08-31T19:57:27.000Z thumbnail image

Stay in the know with updates to Anetumab Ravtansine Multi-indication Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Anetumab Ravtansine Multi-indication Clinical Trial page.